Free Trial

1,706,977 Shares of Procter & Gamble Company (The) $PG Bought by Mirae Asset Global Investments Co. Ltd.

Procter & Gamble logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • Mirae Asset Global Investments acquired 1.71 million Procter & Gamble shares worth approximately $248 million in the third quarter, giving it about a 0.07% stake. Institutional investors collectively own 65.77% of PG.
  • Procter & Gamble exceeded quarterly expectations, reporting $2.00 in earnings per share versus the $1.89 consensus estimate and $23.28 billion in revenue, up 4% year over year. The company also declared a quarterly dividend of $1.0885, equivalent to a 2.7% annualized yield.
  • Analyst sentiment remains broadly favorable, with a “Moderate Buy” consensus and an average price target of $170.57, although ratings are mixed. Meanwhile, company insiders sold $9.27 million of stock over the past three months.
  • MarketBeat previews top five stocks to own in December.

Mirae Asset Global Investments Co. Ltd. purchased a new stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 1,706,977 shares of the company's stock, valued at approximately $247,990,000. Mirae Asset Global Investments Co. Ltd. owned approximately 0.07% of Procter & Gamble as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Northern Financial Advisors Inc boosted its stake in Procter & Gamble by 6.3% in the third quarter. Northern Financial Advisors Inc now owns 6,476 shares of the company's stock worth $941,000 after buying an additional 383 shares in the last quarter. Stevens Capital Partners bought a new position in shares of Procter & Gamble during the 3rd quarter valued at $206,000. Vise Technologies Inc. raised its position in Procter & Gamble by 15.2% in the 3rd quarter. Vise Technologies Inc. now owns 131,794 shares of the company's stock worth $19,147,000 after purchasing an additional 17,395 shares during the period. Investment Partners LTD. lifted its stake in Procter & Gamble by 91.7% in the third quarter. Investment Partners LTD. now owns 15,959 shares of the company's stock worth $2,319,000 after purchasing an additional 7,635 shares during the last quarter. Finally, Summit Global Investments lifted its stake in Procter & Gamble by 47.5% in the third quarter. Summit Global Investments now owns 20,089 shares of the company's stock worth $2,919,000 after purchasing an additional 6,472 shares during the last quarter. 65.77% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CFO Andre Schulten sold 3,914 shares of Procter & Gamble stock in a transaction on Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $568,860.76. Following the completion of the sale, the chief financial officer owned 65,618 shares of the company's stock, valued at $9,536,920.12. The trade was a 5.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Shailesh Jejurikar sold 35,000 shares of Procter & Gamble stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $163.09, for a total transaction of $5,708,150.00. Following the transaction, the chief executive officer owned 55,391 shares in the company, valued at $9,033,718.19. This represents a 38.72% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 58,647 shares of company stock worth $9,268,508 in the last three months. 0.23% of the stock is currently owned by company insiders.

Procter & Gamble Stock Performance

Shares of PG stock opened at $161.42 on Friday. The firm has a market capitalization of $374.14 billion, a price-to-earnings ratio of 24.31, a PEG ratio of 3.97 and a beta of 0.39. The stock has a fifty day moving average of $149.99 and a 200 day moving average of $148.94. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $167.25. The company has a quick ratio of 0.53, a current ratio of 0.72 and a debt-to-equity ratio of 0.40.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, beating the consensus estimate of $1.89 by $0.11. The business had revenue of $23.28 billion for the quarter, compared to analysts' expectations of $22.80 billion. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The business's revenue was up 4.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.99 EPS. As a group, research analysts expect that Procter & Gamble Company will post 6.99 earnings per share for the current year.

Procter & Gamble Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be given a $1.0885 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $4.35 annualized dividend and a yield of 2.7%. Procter & Gamble's dividend payout ratio is 65.51%.

Analyst Ratings Changes

Several research firms have recently commented on PG. Freedom Broker upgraded Procter & Gamble from a "hold" rating to a "buy" rating and set a $176.00 price objective on the stock in a report on Friday, October 23rd. JPMorgan Chase & Co. raised their price target on Procter & Gamble from $162.00 to $180.00 and gave the stock an "overweight" rating in a research report on Friday, October 23rd. Bank of America decreased their price target on Procter & Gamble from $170.00 to $166.00 and set a "buy" rating on the stock in a research note on Friday, July 10th. Evercore upgraded Procter & Gamble from an "in-line" rating to an "outperform" rating and set a $166.00 price objective for the company in a research report on Tuesday, October 6th. Finally, HSBC lowered Procter & Gamble from a "buy" rating to a "hold" rating and dropped their price objective for the company from $182.00 to $149.00 in a research note on Thursday, July 30th. Fifteen analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $170.57.

Read Our Latest Report on Procter & Gamble

Key Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: Analyst upgrade: Freedom Broker upgraded PG from “hold” to “buy,” providing a positive signal for the stock and reflecting greater confidence in the company’s outlook. Freedom Broker upgrades Procter & Gamble to buy from hold
  • Positive Sentiment: Dividend appeal remains strong: Articles highlighted PG as a long-standing dividend leader, supporting its appeal to income-focused and defensive investors. The company’s record of dividend increases may help underpin demand for the shares, particularly when investors favor stable consumer-staples businesses. Dividend Kings article Trusted dividend stocks article
  • Neutral Sentiment: Bond issuance adds balance-sheet context: PG’s euro- and dollar-denominated bond sale provides liquidity and funding flexibility, but it also draws attention to leverage, interest costs, and the company’s relatively elevated valuation. Procter & Gamble bond sale
  • Neutral Sentiment: Growth story under review: Commentary on PG points to accelerating revenue growth, while also noting that higher operating costs could pressure margins and earnings. Investors are weighing improved sales momentum against cost inflation. Procter & Gamble revenue growth and costs What changed in Procter & Gamble’s story
  • Negative Sentiment: Mixed rating signals and valuation risk: DZ Bank downgraded PG from “strong-buy” to “hold.” With shares trading at a premium valuation, a more cautious analyst stance could weigh on upside unless earnings growth accelerates. DZ Bank rating change
  • Negative Sentiment: Advertising challenge produced only a limited win: Following PG’s challenge, the National Advertising Division supported Carpe’s $19.95 reference price but recommended changes or removal of other savings, free-shipping, comparative-performance, and “first” 100-hour protection claims. The outcome may modestly strengthen competitive advertising standards, but it does not represent a material financial catalyst for PG. National Advertising Division decision involving Carpe

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines